BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 35996248)

  • 1. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
    Qiu J; Sun M; Wang Y; Chen B
    Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 4. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of significant genes associated with prognosis of gastric cancer by bioinformatics analysis.
    Wang S; Tao S; Liu Y; Shi Y; Liu M
    J Egypt Natl Canc Inst; 2022 Dec; 34(1):55. PubMed ID: 36567425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma.
    Lin J; Xu N; An W
    J Coll Physicians Surg Pak; 2024 Mar; 34(3):290-295. PubMed ID: 38462863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
    Sadegh K; Ahmadi A
    IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients.
    Wu X; Wu Y; Ye B; Wu F; Wang P
    Medicine (Baltimore); 2020 Jun; 99(26):e20635. PubMed ID: 32590738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
    Alatan H; Chen Y; Zhou J; Wang L
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 15. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
    Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
    Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
    Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
    J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.